Cibus (CBUS) Capital Expenditures (2016 - 2025)
Cibus (CBUS) posted Capital Expenditures of $86000.0 for Q4 2025, down 20.37% sequentially from $108000.0 in Q3 2025, and up 53.57% YoY from $56000.0 in Q4 2024.
Cibus (CBUS) Capital Expenditures (2016 - 2025) Analysis & Trends
Cibus has reported Capital Expenditures for 10 years, with the latest figure at $86000.0 in Q4 2025.
- Quarterly Capital Expenditures rose 53.57% year-over-year to $86000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $578000.0 (down 28.47% YoY) and the FY2025 annual result came in at $578000.0, down 28.47% from the prior year.
- Capital Expenditures eased to $86000.0 in Q4 2025 per CBUS's latest filing, from $108000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.3 million in Q3 2023 and troughed at -$1.3 million in Q2 2021.
- A 5-year average of $337684.2 and a median of $220000.0 in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2021 and 2023: Capital Expenditures tumbled 706.25% in 2021, then surged 3981.82% in 2023.
- Over 5 years, Capital Expenditures stood at $218000.0 in 2021, then sank by 94.95% to $11000.0 in 2022, then soared by 3981.82% to $449000.0 in 2023, then tumbled by 87.53% to $56000.0 in 2024, then soared by 53.57% to $86000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $86000.0, $108000.0, and $93000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 355,000.00 |
| Sep 30, 2024 | 355,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Mar 31, 2024 | 228,000.00 |
| Dec 31, 2023 | 449,000.00 |
| Dec 31, 2023 | 449,000.00 |
| Sep 30, 2023 | 3.31 Mn |
| Sep 30, 2023 | 3.31 Mn |